Highlights & Headlines from Deep Dive: R&D


New year, new Deep Dive. In the first edition of 2023, pharmaphorum’s Deep Dive magazine is back with fresh new formats to explore the biggest trends, challenges, and innovations across the life sciences. 

What are the next steps to achieve real diversity in clinical trials? How does Verily CMO Amy Abernethy see data driving IBD research? And could organ-on-a-chip technology be the key to improving drug development outcomes? 

Check out the latest R&D-focused issue of Deep Dive for answers to these prominent questions, and more: https://deep-dive.pharmaphorum.com/magazine/research-and-development-2023/